International Ophthalmology

, Volume 29, Issue 4, pp 303–304 | Cite as

Citalopram-associated central retinal vein occlusion

  • Alastair D. Hardisty
  • Christopher M. Hemmerdinger
  • Say Aun Quah
Case Report


Diabetic Retinopathy Escitalopram Retinal Vein Occlusion Central Retinal Vein Occlusion Optic Disc Oedema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hayreh SS, Zimmerman MB, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117(4):429–441PubMedGoogle Scholar
  2. 2.
    Skop BOP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective seretonin reuptake inhibitors. Psychosomatics 37:12–16PubMedGoogle Scholar
  3. 3.
    Saur W, Berlin JA, Kimmel SE (2001) Selective seretonin reuptake inhibitors and myocardial infarction. Circulation 104:1894–1898CrossRefGoogle Scholar
  4. 4.
    Stahl SM (1998) Mechanism of action of selective seretonin selective reuptake inhibitors. Seretonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215–235PubMedCrossRefGoogle Scholar
  5. 5.
    Kurne A et al (2004) Venous thromboembolism and escitalopram. Gen Hosp Psychiatry 26:481–483PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Alastair D. Hardisty
    • 1
  • Christopher M. Hemmerdinger
    • 1
    • 2
  • Say Aun Quah
    • 1
  1. 1.Department of OphthalmologyLeighton HospitalCreweCheshireUK
  2. 2.Department of Ophthalmology, St Paul’s Eye Unit, 8Z LinkThe Royal Liverpool University HospitalLiverpoolUK

Personalised recommendations